Novel Nerve Ablation Procedure Explored for HFpEF Splanchnic nerve ablation for volume management passes a feasibility hurdle Oct 11, 2023
Copper-Boosting Agent Promising for Low Ejection Fraction Heart Failure Early-phase study analysis suggests potential for remodeling Oct 10, 2023
Modest Risks Come With Moving Fast on HF Drugs After Acute Event STRONG-HF analysis details the impact Oct 10, 2023
Vagus Nerve Stimulation in Limbo for HFrEF Autonomic regulation therapy trial showed signal for benefit in terminated pivotal trial Oct 09, 2023
Biomarker-Based CardioMEMS Candidates Still Benefit GUIDE-HF trial analysis distinguishes "strata" with different levels of risk Oct 09, 2023
FDA Turns Down ATTR Cardiomyopathy Drug Decision cites insufficient evidence of clinical meaningfulness Oct 09, 2023
Novel Agent Promising as Add-On Epilepsy Treatment Phase IIb trial shows benefit for the most common type of epileptic seizures Oct 09, 2023
Weight-Loss Drug Benefit Spans HFpEF, HFmrEF STEP-HFpEF trial results come out consistent across ejection fraction Oct 08, 2023
Managing Heart Failure Comorbidities Hypertension, atrial fibrillation, type 2 diabetes, and anemia care may require adjustment in HF Oct 02, 2023
For Your Patients: Managing Heart Failure With Other Chronic Conditions Having a combination of HF and other medical issues can impact how you approach each of them Oct 02, 2023